Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
Clinical trial NCT06947083 · RECRUITING
Trial details
- NCT number
- NCT06947083
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2029-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.